CAS No. |
2170212-33-4 |
|---|---|
中文名称 |
LSD1抑制剂-13 |
英文名称 |
LSD1-IN-13 |
别名 |
4-Piperidinemethanamine, N-[(1R,2S)-2-[2,3-dihydro-1-(phenylsulfonyl)-1H-indol-5-yl]cyclopropyl]-, rel-;LSD1-IN-13 |
标准英文名 |
(1R,2S)-2-(1-(phenylsulfonyl)indolin-5-yl)-N-(piperidin-4-ylmethyl)cyclopropan-1-amine |
分子式 |
C23H29N3O2S |
分子量 |
411.57 |
精确分子量 |
411.20 |
SMILES |
O=S(N1CCC2=C1C=CC([C@H]3[C@H](NCC4CCNCC4)C3)=C2)(C5=CC=CC=C5)=O |
标准SMILES |
O=S(=O)(C1C=CC=CC=1)N1CCC2C=C(C=CC1=2)[C@@H]1C[C@H]1NCC1CCNCC1 |
用途 |
LSD1-IN-13 is an orally active LSD1 inhibitor that activates CD86 expression and induces differentiation of acute myeloid leukemia (AML) cell lines. |
InChIKey |
DICMSESOTHCHTP-FCHUYYIVSA-N |
|
|
评论 |
|---|